Friday, July 21, 2017

Breaking News
   Goa will take a hit from 8 K\'taka projects: witness   11 politicos booked in last five years for different offences   2 ministers, 2 figures: What exactly is Zuari bridge cost?   State earned Rs`121 crore from entry tax   Govt relents, amends circular to exclude MLAs and MPs   Cabinet approves amendments to agricultural tenancy act   HC drops anchor on more casinos in River Mandovi   Fomento IT engineer dies in mishap   CM directs DoP to scrutinise plaint against Lobo, Parra p\'yat secy for forgery   Will efforts to expose LPG pilferage go in vain?   No service tax on online rail tickets till Dec 31   Defence Minister Parrikar\'s Nuclear Remark Stressed As \'Personal Opinion   After PM Modi Speech, Hawala (Money-Laundering) Spiked, Triggering Raids   Anger And Scramble To Stash Cash In Black Money Squeeze: Foreign Media   Long queues at banks on Day 1; cash crunch hits State   Customers, bankers kept on toes in Mapusa   Margao business, markets reel under liquidity crunch   Cash curbs paralyse ops in co-op societies   Black money: India to gain access to Swiss bank info from Sept 2019   \'If You Succeed, The Country Succeeds\': Obama Tells Trump During Meet

Sections

Business

Anti-hypertensive drug by Mankind launched

17th May 2017, 06:33 Hrs

A New Delhi based pharmaceutical company called Mankind Pharma has launched an anti-hypertensive drug Zolahart (Azilsartan) at a very affordable price of Rs 7.5 per tablet.


the goan I network
Panaji
  
Speaking on the development, R C Juneja, chairman and founder, Mankind Group, said “We endeavour to bring the latest innovative therapies with assured quality that address primary healthcare challenge in India – world class quality at an affordable price. It is with this thought that we decided to launch Zolahart (Azilsartan), the latest anti-hypertensive drug at the most affordable price of Rs 7.50/Tab, which is 51% less than other competitors.”  
In a press note, Mankind Pharma said, “Azilsartan offers potent and 
persistent 24 hours blood pressure control. It is proven to be safe for hypertensive patients with comorbid conditions like diabetes or chronic kidney disease”
comments powered by Disqus